![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4365 | (2006.01) |
A61K 31/4365 | (2013.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 13/12 | (2018.01) |
(11) | Number of the document | 4125887 |
(13) | Kind of document | T |
(96) | European patent application number | 21715913.6 |
Date of filing the European patent application | 2021-04-02 | |
(97) | Date of publication of the European application | 2023-02-08 |
(45) | Date of publication and mention of the grant of the patent | 2024-02-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2021/058792 |
Date | 2021-04-02 |
(87) | Number | WO 2021/198506 |
Date | 2021-10-07 |
(30) | Number | Date | Country code |
20167687 | 2020-04-02 | EP |
(72) |
BOLZE, Sébastien , FR
FOUQUERAY, Pascale , CH
HALLAKOU-BOZEC, Sophie , FR
|
(73) |
Poxel ,
Immeuble le Sunway
259/261 Avenue Jean Jaures, 69007 Lyon,
FR
|
(54) | USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) |
USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) |